RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $21,250,508 | +208.1% | 19,676,396 | 0.0% | 1.63% | +193.2% |
| Q4 2023 | $6,896,577 | -25.3% | 19,676,396 | 0.0% | 0.56% | -36.7% |
| Q3 2023 | $9,228,230 | -37.4% | 19,676,396 | +46.8% | 0.88% | -24.1% |
| Q2 2023 | $14,745,533 | +39.0% | 13,405,030 | +50.3% | 1.16% | +21.0% |
| Q1 2023 | $10,611,075 | -16.9% | 8,916,870 | +4.0% | 0.96% | -19.4% |
| Q4 2022 | $12,772,086 | – | 8,571,870 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |